Cargando…
Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial
PURPOSE: Continuous sciatic nerve blocks have proven benefits for postoperative analgesia after foot surgery. However, the optimal mode of administration remains a point of debate. Ultrasound guided subparaneural injection accelerates onset time and increases duration after a single shot sciatic ner...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007557/ https://www.ncbi.nlm.nih.gov/pubmed/33790643 http://dx.doi.org/10.2147/LRA.S299870 |
_version_ | 1783672515046932480 |
---|---|
author | Breebaart, Margaretha B Branders, Jordi Sermeus, Luc Termurziev, Sultan Camerlynck, Helene Van Putte, Lennert Van Putte Minelli, Marnik De Hert, Stefan |
author_facet | Breebaart, Margaretha B Branders, Jordi Sermeus, Luc Termurziev, Sultan Camerlynck, Helene Van Putte, Lennert Van Putte Minelli, Marnik De Hert, Stefan |
author_sort | Breebaart, Margaretha B |
collection | PubMed |
description | PURPOSE: Continuous sciatic nerve blocks have proven benefits for postoperative analgesia after foot surgery. However, the optimal mode of administration remains a point of debate. Ultrasound guided subparaneural injection accelerates onset time and increases duration after a single shot sciatic nerve block. This double blind prospective randomized trial compares the 48-hour local anesthetic (LA) dose consumption of an automated intermittent bolus technique to a continuous infusion regimen in a subparaneural sciatic nerve catheter after hallux valgus surgery. PATIENTS AND METHODS: Patients scheduled for hallux valgus surgery were randomized to receive either a continuous infusion of levobupivacaine 0.125% at 5mL/h (group A) or an intermittent automated bolus of 9.8 mL every 2 hours with a background of 0.1 mL/h (group B), both with a PCA bolus of 6 mL and lockout of 30 minutes. The 48 hour LA consumption, PCA boluses, Numeric Rating Scale (NRS), satisfaction and return of normal sensation were recorded. RESULTS: Sixteen patients were excluded because of protocol violation or technical problems and 42 patients remained for analysis. The 48 hour ropivacaine consumption was higher in group A (293 ±60 mL) than group B (257±33 mL). The median and highest NRS scores and patient satisfaction were not statistically different between groups. Normal sensation returned after 75 ± 22 hours (group A) and 70 ± 17 hours (group B). CONCLUSION: Programmed bolus administration in subparaneural sciatic nerve catheters reduces LA consumption 48 hours after surgery with equal analgesia and patient satisfaction. Return of sensation is variable and can last more than 75 hours. |
format | Online Article Text |
id | pubmed-8007557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-80075572021-03-30 Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial Breebaart, Margaretha B Branders, Jordi Sermeus, Luc Termurziev, Sultan Camerlynck, Helene Van Putte, Lennert Van Putte Minelli, Marnik De Hert, Stefan Local Reg Anesth Clinical Trial Report PURPOSE: Continuous sciatic nerve blocks have proven benefits for postoperative analgesia after foot surgery. However, the optimal mode of administration remains a point of debate. Ultrasound guided subparaneural injection accelerates onset time and increases duration after a single shot sciatic nerve block. This double blind prospective randomized trial compares the 48-hour local anesthetic (LA) dose consumption of an automated intermittent bolus technique to a continuous infusion regimen in a subparaneural sciatic nerve catheter after hallux valgus surgery. PATIENTS AND METHODS: Patients scheduled for hallux valgus surgery were randomized to receive either a continuous infusion of levobupivacaine 0.125% at 5mL/h (group A) or an intermittent automated bolus of 9.8 mL every 2 hours with a background of 0.1 mL/h (group B), both with a PCA bolus of 6 mL and lockout of 30 minutes. The 48 hour LA consumption, PCA boluses, Numeric Rating Scale (NRS), satisfaction and return of normal sensation were recorded. RESULTS: Sixteen patients were excluded because of protocol violation or technical problems and 42 patients remained for analysis. The 48 hour ropivacaine consumption was higher in group A (293 ±60 mL) than group B (257±33 mL). The median and highest NRS scores and patient satisfaction were not statistically different between groups. Normal sensation returned after 75 ± 22 hours (group A) and 70 ± 17 hours (group B). CONCLUSION: Programmed bolus administration in subparaneural sciatic nerve catheters reduces LA consumption 48 hours after surgery with equal analgesia and patient satisfaction. Return of sensation is variable and can last more than 75 hours. Dove 2021-03-25 /pmc/articles/PMC8007557/ /pubmed/33790643 http://dx.doi.org/10.2147/LRA.S299870 Text en © 2021 Breebaart et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report Breebaart, Margaretha B Branders, Jordi Sermeus, Luc Termurziev, Sultan Camerlynck, Helene Van Putte, Lennert Van Putte Minelli, Marnik De Hert, Stefan Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title | Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title_full | Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title_fullStr | Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title_full_unstemmed | Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title_short | Levobupivacaine Consumption in Automated Intermittent Bolus in Ultrasound Guided Subparaneural Sciatic Nerve Catheters: A Prospective Double-Blind Randomized Trial |
title_sort | levobupivacaine consumption in automated intermittent bolus in ultrasound guided subparaneural sciatic nerve catheters: a prospective double-blind randomized trial |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007557/ https://www.ncbi.nlm.nih.gov/pubmed/33790643 http://dx.doi.org/10.2147/LRA.S299870 |
work_keys_str_mv | AT breebaartmargarethab levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT brandersjordi levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT sermeusluc levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT termurzievsultan levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT camerlynckhelene levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT vanputtelennert levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT vanputteminellimarnik levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial AT dehertstefan levobupivacaineconsumptioninautomatedintermittentbolusinultrasoundguidedsubparaneuralsciaticnervecathetersaprospectivedoubleblindrandomizedtrial |